PMA device
ENROUTE Transcarotid Stent System
Boston Scientific Corporation · Stent, Carotid (NIM, Class III) · First FDA decision May 18, 2015, newest Jul 20, 2023Carotid artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
12
PMA pathway
Device trials
4
Naming "ENROUTE Transcarotid"
MAUDE reports
1,045
Brand "ENROUTE Transcarotid", since 2015
PubMed studies
20
Mentioning "ENROUTE Transcarotid"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ENROUTE Transcarotid Stent System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 12 decisions filed under this name.
- ENROUTE Transcarotid Stent SystemPMA supplement
P140026-S027 · Decided Jul 20, 2023 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, carotid (NIM) · Cardiology
5 more FDA decisions with a free account
Older decisions: P140026-S010, P140026-S006, P140026-S005, P140026-S002, P140026-S001, P140026
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R8Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R7Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R6Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R3Updated Sep 21, 2026
- Carotid Artery Stenting in Post-Approval StudiesNational analysisReview closedCAG-00259NUpdated Sep 17, 2026
- Carotid Artery StentingNational analysisReview closedCAG-00085RUpdated Sep 17, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "ENROUTE Transcarotid", any status and sponsor, newest update first.
- A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese PopulationNot yet recruiting
Boston Scientific CorporationPublic (BSX)
NCT07458243 · 60 participants (planned) · Start Feb 28, 2027 · Primary completion Sep 30, 2027
Device: transcarotid artery revascularization · For: Carotid Artery Stenosis
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ENROUTE Transcarotid", and for the whole product code for context.
This brand
1,045 reports: 58 malfunction, 944 injury, 43 death
Whole product code NIM
2,799 reports: 1,699 malfunction, 994 injury, 98 death
Newest reports for this brand
2124215-2026-57732 · Received Oct 30, 2026 · Event dated Sep 18, 2026
Device type: Temporary Carotid Catheter For Embolic Capture (NTE)
Device problem as coded: Insufficient Flow or Under Infusion
Patient problem as coded: Hematoma; Muscle Weakness/Atrophy; Ischemia Stroke
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1146-2021 · Started Jan 13, 2021
Reason given: Due to complaints received that the tip/nose cone may detach from the Transcarotid Stent System.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stent, Carotid (NIM)
Published research
The most relevant PubMed records for "ENROUTE Transcarotid"[tiab]. The summary above synthesizes these.
- Transcarotid Artery Revascularization With Flow Reversal.
Alpaslan A, Wintermark M, Pintér L, et al. · J Endovasc Ther · 2017Clinical Trial, Phase III, Research Support, Non-U.S. Gov't
- Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system.
Malas MB, Leal J, Kashyap V, et al. · J Vasc Surg · 2017
- Avoiding Complications with Transcarotid Artery Revascularization.
Lewis AJ, Maningat A, Salzler GG, et al. · Ann Vasc Surg · 2025Review
- One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial.
Kashyap VS, So KL, Schneider PA, et al. · J Vasc Surg · 2022Multicenter Study, Research Support, Non-U.S. Gov't
- The learning curve of transcarotid artery revascularization.
King AH, Kumins NH, Foteh MI, et al. · J Vasc Surg · 2019Multicenter Study
- Novel use of the ENROUTE transcarotid arterial sheath for antegrade cerebral perfusion during retrograde innominate stenting.
Barnes JA, Columbo JA, Kuwayama DP · J Vasc Surg Cases Innov Tech · 2020
- Carotid artery dissections from transcarotid artery revascularization as reported by the Food and Drug Administration.
Suh D, Ma Y, Newton DH, et al. · Vascular · 2024
- Anatomic eligibility for transcarotid artery revascularization and transfemoral carotid artery stenting.
Wu WW, Liang P, O'Donnell TFX, et al. · J Vasc Surg · 2019Comparative Study, Research Support, N.I.H., Extramural
- Use of a dedicated open transcarotid access system for neurovascular disease.
Sujijantarat N, Renedo D, Antonios J, et al. · J Neurointerv Surg · 2025
- Technical tips for success in transcarotid artery revascularization.
Schroeder AC, Balceniuk MD, Sebastian A, et al. · Semin Vasc Surg · 2020
- A multi-institutional analysis of transcarotid artery revascularization compared to carotid endarterectomy.
Kashyap VS, King AH, Foteh MI, et al. · J Vasc Surg · 2019Comparative Study, Multicenter Study
- The rising utilization and associated outcomes of transcarotid arterial revascularization.
Crisostomo P, Pinto Rodriguez P, Khan N, et al. · Int Angiol · 2025Review
Other devices of this type
Also filed under product code NIM.
- XACT® Carotid Stent SystemAbbott Vascular, Inc. · PMA 2025
- Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2016
- Carotid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2024
- Acculink Carotid Stent System and Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2017
- Roadsaver/CASPER Carotid Stent DeviceMicroVention, Inc. · PMA 2025
- Cartoid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2012
- Protege Gps & Protege Rx Carotid Stent SystemsMedtronic Vascular, Inc. · PMA 2011
- Cordis Precise Nitinol StentCordis US Corporation · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.